Cornerstone Therapeutics, a specialty pharmaceutical company, has reported that Chenyqua Baldwin, the company's vice president of finance and chief accounting officer, has resigned.
Subscribe to our email newsletter
Cornerstone Therapeutics said that it has already begun a search for a successor.
Craig Collard, Cornerstone’s president and CEO, said: “I would like to thank Chenyqua for her significant contributions to Cornerstone over the past five years. Chenyqua has been an integral part of the growth of the company to date and we wish her success as she moves on to new challenges.”
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.